National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No. 11) (No. PB 77 of 2011) (Cth)
National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.11)
Instrument number PB 77 of 2011
National Health Act 1953
I, CLARE STARR, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 20 October 2011
CLARE STARR
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.11).
(2) This Determination may also be cited as PB 77 of 2011.
Commencement
This Determination commences on 1 November 2011.
Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Eletriptan
Insert
Eltrombopag
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See
0
0
0